Physical and Rehabilitation Medicine, Department of Health Sciences, University of Eastern Piedmont A. Avogadro, AOU Maggiore della Carità, Viale Piazza D'armi 1, 28100 Novara, Italy.
Eur J Endocrinol. 2012 Oct;167(4):491-7. doi: 10.1530/EJE-12-0362. Epub 2012 Aug 7.
Normocalcemic primary hyperparathyroidism (PHPT-N) is a condition that may have similar long-term implications to primary hyperparathyroidism (PHPT); however, differential diagnosis and treatment for parathyroid disorders are not clearly defined. We investigated the effect of an oral peptone and an oral calcium load on calcium-regulating hormones in PHPT-N compared with PHPT and healthy controls to provide a new potential diagnostic tool.
Case-control study.
We evaluated serum gastrin, PTH, ionized calcium, and phosphate responses to oral calcium (1 g) and peptone (10 g) load in 22 PHPT and 20 PHPT-N patients matched for PTH serum values. Moreover, 30 healthy subjects were enrolled as controls. In 12 patients for each group, we also performed the oral peptone test adding aluminum hydroxide (AH) to suppress phosphate absorption.
In PHPT patients, PTH increased significantly 30 min after the oral peptone load, while no significant increase was found in PHPT-N and controls. After oral calcium load, PTH remained stable in PHPT while it decreased dramatically in PHPT-N patients, and ionized calcium increased significantly in each of the three groups. Peptones plus AH induced a blunted PTH increase in the three groups.
Considering the marked difference in PTH response elicited by peptones in PHPT compared with PHPT-N, we suggest that the oral peptone test could be added to the diagnostic evaluation of PHPT patients. In case of absent response to peptones, patients should have their serum calcium levels assessed twice a year in accordance with recent guidelines.
血钙正常型原发性甲状旁腺功能亢进症(PHPT-N)可能与原发性甲状旁腺功能亢进症(PHPT)具有相似的长期影响,但甲状旁腺疾病的鉴别诊断和治疗方法尚未明确。我们研究了口服蛋白胨和钙负荷对 PHPT-N 与 PHPT 和健康对照组钙调节激素的影响,以期为其提供一种新的潜在诊断工具。
病例对照研究。
我们评估了 22 例 PHPT 和 20 例 PHPT-N 患者(根据血清甲状旁腺激素值匹配)以及 30 例健康对照者口服钙(1 g)和蛋白胨(10 g)负荷后血清胃泌素、甲状旁腺激素、离子钙和磷酸盐的反应。此外,在每组 12 例患者中,我们还添加了氢氧化铝(AH)以抑制磷酸盐吸收,进行了口服蛋白胨试验。
在 PHPT 患者中,口服蛋白胨 30 分钟后甲状旁腺激素显著增加,而 PHPT-N 和对照组无明显增加。口服钙负荷后,PHPT 患者的甲状旁腺激素保持稳定,而 PHPT-N 患者的甲状旁腺激素则显著下降,三组患者的离子钙均显著增加。在三组中,蛋白胨加 AH 诱导的甲状旁腺激素增加减弱。
鉴于 PHPT 患者与 PHPT-N 患者口服蛋白胨后甲状旁腺激素反应存在显著差异,我们建议将口服蛋白胨试验纳入 PHPT 患者的诊断评估。如果对蛋白胨无反应,应根据最近的指南,每年两次评估患者的血清钙水平。